Ming Zhao, M.D., M.S
School of Health Professions, Division of Chief Academic Officer
Present Title & Affiliation
Primary Appointment
Associate Professor, The School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Program Director, Cytogenetic Technology Program, The School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2008 | School of Health Professions, U.T. M.D. Anderson Cancer, Houston, Texas, US, BS in Cytogenetic Technology |
| 1998 | Peking Union Medical College, Beijing, CN, M.S. in Biochemistry |
| 1991 | West China University of Medical Sciences (currently West China Medical Center of Sichuan University), Chengdu, CN, MD (U.S equivalent) |
Licenses & Certifications
| 2011 | MB(ASCP) |
| 2008 | CG(ASCP) |
Experience & Service
Faculty Academic Appointments
Assistant Professor, School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - 2022
Intramural Institutional Committee Activities
Member, SHP Summer Research Review Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, School of Health Professions Cytotechnology Program Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Chair, School of Health Professions Faculty Progress Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, School of Health Professions Curriculum Subcommittee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, School of Health Professions Educational Technology Advisory Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, School of Health Professions Catalogue Subcommittee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Cytotechnology Program Admission Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Faculty Progress Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Chair, School of Health Professions Cytogenetic Program Instructor Search Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Molecular Genetic Program Instructor Search Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Academic Affairs Committee (AAC), The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Mid-Career faculty Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Student Conduct & Discipline Hearing Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, School of Health Professions Molecular Genetic Program Instructor Search Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, School of Health Professions QEP & IDCS, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, School of Health Professions Diagnostic Genetic Master Program Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, School of Health Professions Classroom Schedule Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Chair, School of Health Professions Diagnostic Genetic Master Program Admission Committee, The University of Texas MD Anderson Cancer Center, 2019
Reviewer, King Foundation High School Summer Program Admission, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, School of Health Professions Diagnostic Genetic Master Program Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, School of Health Professions Molecular Genetic Program Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, School of Health Professions Diagnostic Genetic Master Program Admission Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, School of Health Professions Cytogenetic Technology Program Admission Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present
Extramural Institutional Committee Activities
Member, School of Health Professions Faculty Progress Review Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Education Director at-large, Association of Genetic Technologists (AGT), Association of Genetic Technologists (AGT), 2024 - Present
Vice Chair, American Society for Clinical Pathology (ASCP) Board of Certification Examination Committee, American Society for Clinical Pathology, 2024 - Present
Member, American Society for Clinical Pathology (ASCP) Board of Certification Examination Committee, American Society for Clinical Pathology, 2020 - 2024
Honors & Awards
| 2018 - 2023 | Faculty Inductee, The Alpha Eta Society, The National Scholastic Honor Society for Allied Health Professions |
| 2016 - Present | Performance reward, the School of Health Professions, University of Texas M.D. Anderson Cancer Center |
| 2015 - 2016 | Performance Reward, School of Health Professions, University of Texas M.D. Anderson Cancer Center |
| 2012 - Present | Outstanding Educator of the Year, School of Health Professions, University of Texas M.D. Anderson Cancer Center |
| 2011 - 2012 | Outstanding Educator of the Year, School of Health Professions, University of Texas M.D. Anderson Cancer Center |
| 2011 | Staff Educator of the Month Award, University of Texas M.D. Anderson Cancer Center |
| 2008 | Honored Graduate, School of Health Sciences, University of Texas M.D. Anderson Cancer Center |
| 2008 | Jane and Phil Yeckel Scholarship, School of Health Sciences, University of Texas M.D. Anderson Cancer Center |
| 2008 | EXCEL Award, The Foundation For Genetic Technology |
| 2007 | XIXth Testis workshop & American Society of Andrology Oral Talk Award, American Society of Andrology |
| 2003 | XVIIth Testis workshop & American Society of Andrology Travel Award, American Society of Andrology |
| 1991 | Shi-Zhenxin Public Health Scholarship, China International Medical Foundation |
| 1991 | Outstanding Graduate, West China University of Medical Sciences |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2026. HER2 Status Conversion in Residual Breast Carcinoma After Neoadjuvant Anti-HER2 Therapy: Prognostic and Therapeutic Implications. Poster. 2026 USCAP Annual Meeting. San Antonio, Texas, US.
- 2023. Investigation of TRPS1 Copy number variations/Rearrangements in Breast Cancer Using Homebrewed FISH Probe Set. Conference. 2023 ASCLS &AGT Annual Meeting. Providence, Rhode Island, US.
- 2020. Investigation of MECOM rearrangement in a Myelodysplastic Syndrome (MDS) Case with t(3;6)(q26.2;q21) using two sets of breakapart probe. Poster. 2020 ASCLS &AGT Annual Meeting. Houston, Texas, US.
- 2018. c-myc Rearrangement Involved in Myeloid Neoplasms Associated with the t(3;8)(q26.2;q24). Poster. 138th Annual Meeting of the Association of Clinical Scientists. Houston, Texas, US.
- 2017. Chromosome 8p12-21 Alteration in Non-small Cell Lung Cancer. Conference. 42th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2017. Clinical Validation of a Dual-color FISH Probe Assay For IRF4/Dusp22. Conference. 42th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2017. Automated metaphase finding and FISH spot counting validation. Conference. 42th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2015. PAX5 rearrangement in plasma cell myeloma. Conference. 40th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2014. Genetic alterations of acute lymphoblastic leukemia detected by array CGH: Meta-analysis of 13 studies and 1428 subjects. Conference. 39 th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2014. Detection of C-myc amplification by FISH analysis. Conference. 39 th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2014. Conventional FISH verus CIG-FISH: Meta-analysis comparing detection rates in patients with multiple myeloma. Conference. 39 th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2014. Genetic hotspots of autism detected by array CGH: A systematic review. Conference. 39 th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2013. Application of BAC probe FISH in evaluating two fragiles sites dusp22 and rfa7h gene for T-cell lymphomas. Conference. 38th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2013. B-lymphoblastic leukemia with t(14;19)(q32;p13.1) involves the IGH and EPOR genes and is associated with an aggressive clinical course. Conference. United States & Canadian Academy of Pathology Annual Meeting. Houston, Texas, US.
- 2013. Chd5 orchestrates chromatin remodeling during spermiogenesis. Conference. Epigenetics & Chromatin: Interactions and processes Meeting” at Harvard Medical School in Boston. Houston, Texas, US.
- 2013. Development of FISH probe panel for chromosomal aberrations detection in pancreatic adenocarcinoma. Conference. 38th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2013. CpG oligonucleotide/IL-2 bone marrow culture benefits for CLL detection in comparison with standard culture. Conference. 38th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2013. Implications of C-rel gene amplication in diffuse large B-cell lymphoma outcome. Conference. 38th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2012. The prognostic effect on the absence or presence of t(11;18)(q21;q21) and secondary genetic aberrations in patients with gastric malt lymphoma. Conference. 37th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2012. Cytoclear: Improve Quality of Bone marrow Metaphases. Conference. 37th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2012. Use of Spectral Karyotyping and FISH to determine Chromosomal Aberrations and Spatial Gene Locations in Hematological Disease. Conference. 37th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2012. Acquired isolated de(20q) in treated plasma cell myeloma patients: the first report of 10 cases in the literature. Conference. 37th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Clinical response to letrozole is better than tamoxifen in HR/HER2 positive breast carcinoma patients. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Genetic defects revealed by array comparative genpmic hybridization for patients with mental retardation and developmental delay phenotype. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Survival outcomes associated with Bcl-6 gene rearrangement in diffuse large B-cell lymphoma: a meta-analysis. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Meta-analusis re-evaluation QF-PCR and FISH in the detection of the most common prenatal aneuploidies. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. The frequency of IGH(14q32) rearrangement variants and other chromosomal abnormalities for multiple myeloma: systematic review and meta analysis. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Array comparative genomic hybridization and FISH correlation in the detection of genetic aberrations in chronic lymphocytic leukemia. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. EGFR amplification and over-expression are associated with longer overall survival for patients with non-small cell lung cancer: a meta-analysis. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Correlation between FISH and chromosome karyotyping in the detection of William Beuren syndrome. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Meta-analysis of automated versus manual scoring of HER2 gene by FISH shows discordance. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Clonal evolution may predict resistance of tyrosine kinase inhibitors in patients with chronic myelogenous leukemia. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Assessing the sensitives and diagnostic power of FISH and routine cytology in cases of pancreatic neoplasms: systematic review and meta-analysis. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. FISH offers greater outcomes for preimplantation genetic diagnosis than PCR in patients with recurrent pregnancy loss due to robertsonian translocations. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2011. Significantly increased detection rate of risk cytogenomic markers by interphase FISH on enriched myeloma cells. Conference. United States & Canadian Academy of Pathology Annual Meeting. Houston, Texas, US.
- 2011. No increase in FISH abnormalities observed in cervical lesions positive HPV infection. Conference. 36th Association of Genetic Technologists Annual Meeting. Houston, Texas, US.
- 2007. Defective processing of 18S rRNA in spermatocytes of juvenile spermatogonial depletion (jsd) mice. Conference. XIX North American Testis Workshop & 32th Annual Meeting of American Society of Andrology. Houston, Texas, US.
- 2005. Cell- and tissue-specific distribution of expression of genes (Utp14a, Utp14b) involved in Juvenile spermatogonial depletion mutation in mouse. Conference. XVIII North American Testis Workshop. Houston, Texas, US.
- 2004. Transition nuclear proteins are required for normal chromatin condensation and functional sperm development. Conference. Cold Spring Harbor Meetings on Germ Cells workshop. Houston, Texas, US.
- 2003. Replacement of nucleoproteins during mouse spermiogenesis. Conference. XVIIth North American Testis Workshop & 28th Annual Meeting of American Society of Andrology. Houston, Texas, US.
- 2002. Transition Protein Level Changes in Mice with Abnormal Copies of Tnp1 or Tnp2 Gene. Conference. 35th Annual Meeting of American Society for the Study of Reproduction. Houston, Texas, US.
- 2001. Targeted disruption of TP2 subtly affect spermatogenesis in mice. Conference. XVIth North American Testis Workshop. Newport Beach, CA, US.
International Presentations
- 2025. Optical Genome Mapping (OGM) and its Application Cancer Diagnosis. Invited. 50th Mexico National and 9th Latin-American Conference of Human Genetics. Puerto Vallarta, MX.
- 2025. Experiences in Cytogenetics Reports. Invited. Diagnostic Excellence in Cytogenetics: International Standards and Good Practices in the Era of Genomics Workshop in 50th Mexico National and 9th Latin-American Conference of Human Genetics. Puerto Vallarta, MX.
- 2025. Fundamentals and Documentation for Methodologies in the Cytogenetics Laboratory (ISO 15189:2022). Invited. Diagnostic Excellence in Cytogenetics: International Standards and Good Practices in the Era of Genomics Workshop in 50th Mexico National and 9th Latin-American Conference of Human Genetics. Puerto Vallarta, MX.
- 2025. FISH ISCN (2024). Invited. Diagnostic Excellence in Cytogenetics: International Standards and Good Practices in the Era of Genomics Workshop in 50th Mexico National and 9th Latin-American Conference of Human Genetics. Puerto Vallarta, MX.
- 2019. Making Home-brew FISH probe and Probe Validation. Invited. Clinical Cytogenetic and Molecular Genetic Diagnosis Workshop. Monterrey, MX.
- 2019. Next-generation DNA Sequencing and Its Clinical Applications. Invited. Clinical Cytogenetic and Molecular Genetic Diagnosis Workshop. Monterrey, MX.
- 2019. aCGH and its Clinical Applications. Invited. Clinical Cytogenetic and Molecular Genetic Diagnosis Workshop. Monterrey, MX.
- 2019. Bone Marrow Setup and Culture. Invited. Clinical Cytogenetic and Molecular Genetic Diagnosis Workshop. Monterrey, MX.
- 2019. Conventional Cytogenetic Techniques and FISH. Invited. Clinical Cytogenetic and Molecular Genetic Diagnosis Workshop. Monterrey, MX.
- 2006. Cell- and tissue-specific distribution of expression of genes (Utp14a, Utp14b) involved in Juvenile spermatogonial depletion mutation in mouse. Conference. Cell- and tissue-specific distribution of expression of genes (Utp14a, Utp14b) involved in Juvenile spermatogonial depletion mutation in mouse. Bavaria, DE.
Formal Peers
- 2021. FISH Troubleshooting. Houston, Texas, US.
- 2020. FISH Troubleshooting. Invited, US.
- 2019. Clinical Cytogenetic and Molecular Genetic Diagnosis. Invited. Monterrey, Nuevo Leon, MX.
- 2015. Array-CGH & SNP Array Validation Data Interpretation & Quality Control. Invited. Savannah, GA, US.
- 2014. Array-CGH & SNP Array Validation Data Interpretation & Quality Control. Invited. Louisville, KY, US.
- 2013. Clinical Cytogenetic and Molecular Genetic Diagnosis. Invited. Monterrey, Nuevo Leon, MX.
- 2013. How to Validate Array-CGH in the Cytogenetics Lab. Invited. Las Vegas, NV, US.
- 2012. Interpret Array CGH Data. Invited. Atlanta, GA, US.
- 2011. Interpret Array CGH Data. Invited. Minneapolis, MN, US.
Selected Publications
Peer-Reviewed Articles
- Raval P, Ding Q, Singh P, Alrohaibani A, Sun H, Ai, D, Wanis K, Zhao, M, Chen H, Valero V, Gregor M, Sahin A. HER2 Status Conversion in Residual Breast Carcinoma After Neoadjuvant HER2-Targeted Therapy in Patients with HER2-Positive Breast Cancer. BCRT. e-Pub 2026.
- Li C, Cheng X, Liu W, Zou G, Nguyen THM, Zhao E, Ira N, Zeng L, Fan Y, Dhar S, Wang G, Song S, Zhao M, Zhang R, Lo YH, Yap T, Ajani J, Peng G. ARID1A deficiency unleashes centromeric RNA transcription to drive chromosomal instability and boosts PKMYT1 inhibitor efficacy via RNA sensing. Nature Communication. e-Pub 2026.
- Mak PY, Mohanty V, Wu X, Ayoub E, Tao W, Zhao M, Boettcher S, Issa G, Chen K, Andreeff M, Carter B. Reversing acquired and primary resistance to menin inhibition in acute myeloid leukemia through inhibition of RAS and fatty acid metabolism. Haematologica. e-Pub 2025.
- Vanjari, N, Tang, G, Toruner, GA, Wang, W, Thakral, B, Zhao, M, Dave, BJ, Khoury, J, Medeiros, LJ, Tang, Z. Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review. Genes 14(12), 2023. e-Pub 2023. PMID: 38137010.
- Cai, T, Gouble, A, Black, KL, Skwarska, A, Naqvi, AS, Taylor, D, Zhao, M, Qi, Y, Sugita, M, Zhang, Q, Galetto, R, Filipe, S, Cavazos, A, Han, L, Kuruvilla, VM, Ma, H, Weng, C, Liu, C, Liu, X, Konoplev, SN, Gu, J, Tang, G, Su, X, Al-Atrash, G, Ciurea, S, Neelapu, SS, Lane, AA, Kantarjian, HM, Guzman, ML, Pemmaraju, N, Smith, J, Thomas-Tikhonenko, A, Konopleva, M. Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nature communications 13(1), 2022. e-Pub 2022. PMID: 35484100.
- Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Touruner GA, Hu S, Yin C, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly Designed Breakapart FISH Probe Identify Cases with True MECOM Rearrangement in Myeloid Malignancies. Cancer Genetics 262-263:23-29, 2022. e-Pub 2022.
- Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. American Journal of Cancer Research 9(6):1201-1211, 2019. e-Pub 2019.
- Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z. t(3;8)(q26.2;q24) Often Leads to MECOM /MYC Rearrangement and is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. Journal of Molecular Diagnostics 21(2):343-351, 2019. e-Pub 2019.
- Naofal ME, Kim A, Yon HY, Baity M, Zhao M, Bui-Griffith J, Tang Z, Robinson M, Grubbs EG, Cote GJ, and Hu P. Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma. Annals of Clinical and Laboratory Science 47(5):523-528, 2017. e-Pub 2017.
- Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu G. B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol 27(3):382-9, 2014. e-Pub 2014. PMID: 24030742.
- Qdaisat S, Zhao M, Qdaisat A, Harper AE, Gu J, Hopwood V. Bone Marrow Cultures Stimulated with IL-2/CpG Oligonucleotide Benefits Chromosomal Aberration Detection of CLL Patients when Compared with Standard Culture. Journal of the Association of Genetic Technologists 40(4):219-222, 2014. e-Pub 2014.
- Li W, Wu J, Kim SY, Zhao M, Hearn SA, Zhang MQ, Meistrich ML, Mills AA. Chd5 orchestrates chromatin remodelling during sperm development. Nat Commun 5:3812, 2014. e-Pub 2014. PMID: 24818823.
- Lu G, Muddasani R, Orlowski RZ, Abruzzo LV, Qazilbash MH, You MJ, Wang Y, Zhao M, Chen S, Glitza IC, Medeiros LJ. Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms. Arch Pathol Lab Med 137(5):625-31, 2013. e-Pub 2013. PMID: 23627452.
- Iwamori N, Zhao M, Meistrich ML, Matzuk MM. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 84(6):1225-34, 2011. e-Pub 2011. PMID: 21293030.
- Yang L, Wang H, Kornblau SM, Graber DA, Zhang N, Matthews JA, Wang M, Weber DM, Thomas SK, Shah JJ, Zhang L, Lu G, Zhao M, Muddasani R, Yoo SY, Baggerly KA, Orlowski RZ. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma. Oncogene 30(11):1329-40, 2011. e-Pub 2011. PMID: 21057542.
- Wang SA, Abruzzo LV, Hasserjian RP, Zhang L, Hu Y, Zhang Y, Zhao M, Galili N, Raza A, Medeiros LJ, Garcia-Manero G, Miranda RN. Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features. Leuk Res 35(3):351-7, 2011. e-Pub 2011. PMID: 20691474.
- Ishibashi T, Li A, Eirín-López JM, Zhao M, Missiaen K, Abbott DW, Meistrich M, Hendzel MJ, Ausió J. H2A.Bbd: an X-chromosome-encoded histone involved in mammalian spermiogenesis. Nucleic Acids Res 38(6):1780-9, 2010. e-Pub 2010. PMID: 20008104.
- Zhao M, Rohozinski J, Sharma M, Ju J, Braun RE, Bishop CE, Meistrich ML. Utp14b: a unique retrogene within a gene that has acquired multiple promoters and a specific function in spermatogenesis. Dev Biol 304(2):848-59, 2007. e-Pub 2007. PMID: 17291484.
- Bhattacharya C, Aggarwal S, Zhu R, Kumar M, Zhao M, Meistrich ML, Matin A. The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Biochem Biophys Res Commun 355(1):194-9, 2007. e-Pub 2007. PMID: 17291453.
- Wang RA, Zhao M, Meistrich ML, Kumar R. Stage-specific expression of dynein light chain-1 and its interacting kinase, p21-activated kinase-1, in rodent testes: implications in spermiogenesis. J Histochem Cytochem 53(10):1235-43, 2005. e-Pub 2005. PMID: 15983119.
- Zhao M, Shirley CR, Mounsey S, Meistrich ML. Nucleoprotein transitions during spermiogenesis in mice with transition nuclear protein Tnp1 and Tnp2 mutations. Biol Reprod 71(3):1016-25, 2004. e-Pub 2004. PMID: 15163613.
- Zhao M, Shirley CR, Hayashi S, Marcon L, Mohapatra B, Suganuma R, Behringer RR, Boissonneault G, Yanagimachi R, Meistrich ML. Transition nuclear proteins are required for normal chromatin condensation and functional sperm development. Genesis 38(4):200-13, 2004. e-Pub 2004. PMID: 15083521.
- Zhao M, Shirley CR, Yu YE, Mohapatra B, Zhang Y, Unni E, Deng JM, Arango NA, Terry NH, Weil MM, Russell LD, Behringer RR, Meistrich ML. Targeted disruption of the transition protein 2 gene affects sperm chromatin structure and reduces fertility in mice. Mol Cell Biol 21(21):7243-55, 2001. e-Pub 2001. PMID: 11585907.
- Liu, HX, Zhao, M, Miao, SY, Wang, LF. Isolation and characterization of a novel, stage-specific full-length cDNA during spermatogenesis. Acta Academiae Medicinae Sinicae(21), 1999. e-Pub 1999.
- Wang, CH, Wang, PY, Leng, XG, Zhao, M, Liu, WG, Shi, HL. Influence of Polyvinylchloride Catheter on Blood Tissue Factor Activity. Chinese Journal of Biomedical Engineering(18):231-233, 1999. e-Pub 1999.
- Zhao, M, Liu, HX, Liu, DY, Miao, SY, Wang, LF. Preliminary study of stage-specific gene expression during rat spermatogenesis, using mRNA differential display. Basic Medical Sciences and Clinics(12):414-418, 1999. e-Pub 1999.
- Shi, HL, Zhao, M, Wu, D, Wang, PY. Effect of the Long-Acting Degradable Delivery Drug Film on the Impaired Periodontium of Rats. Biomedical Engineering and Clinics(2):88-90, 1998. e-Pub 1998.
- Wang, PY, Zhao, M, Liu, WG, Wang, CH. Effect of biomedical polymers on tissue factor activity expressed on monocytes in vitro. Chinese Journal of Biomedical Engineering (English Edition)(2):85-89, 1997. e-Pub 1997.
- Zhao, M. Role of Aggrecan in the Pathogenesis of Rheumatoid Arthritis. Basic Medical Sciences and Clinics(17):93-98, 1997. e-Pub 1997.
- Zhao, M. Tissue factor pathway inhibitor (TFPI). Chinese Journal of Hematology(16):495-497, 1995. e-Pub 1995.
Review Articles
- Meistrich ML, Mohapatra B, Shirley CR, Zhao M. Roles of transition nuclear proteins in spermiogenesis. Chromosoma 111(8):483-8, 2003. e-Pub 2003. PMID: 12743712.
Book Chapters
- Zhao M, Siu Lee, Jeff Sanford, Peter Hu. Chapter 15. Fluorescence in situ hybridization. In: The AGT Cytogenetics & Cytogenomic Laboratory Manual 5th. Wiley Blackwell.
Patient Reviews
CV information above last modified July 27, 2026